PDF(1045 KB)
早期应用重组人促红细胞生成素对早产儿脑白质发育的影响
杨淑铄, 徐发林, 程慧清, 徐昊冉, 杨林, 邢景月, 程琳
中国当代儿科杂志 ›› 2018, Vol. 20 ›› Issue (5) : 346-351.
PDF(1045 KB)
PDF(1045 KB)
早期应用重组人促红细胞生成素对早产儿脑白质发育的影响
Effect of early application of recombinant human erythropoietin on white matter development in preterm infants
目的 应用磁共振弥散张量成像（DTI）的部分各项异性参数（FA）评价早期应用重组人促红细胞生成素（rhEPO）对早产儿脑白质发育的影响。方法 以81例胎龄≤ 32周、出生体重 < 1 500 g、生后24 h内住院的早产儿为研究对象，随机分为两组：rhEPO组（42例）使用rhEPO治疗，对照组（39例）使用等体积的生理盐水注射。2组均于纠正胎龄35~37周行头部MRI、DWI、DTI检查，并测定相同感兴趣区的部分各项异性参数（FA）。结果 两组早产儿颅内出血、脑室周围白质软化、局灶性脑白质损伤、广泛性脑白质损伤等发生率的差异无统计学意义（P > 0.05）。rhEPO组早产儿内囊后肢、胼胝体压部、额叶白质、枕叶白质FA值高于对照组（P < 0.05），2组早产儿顶叶白质、丘脑、豆状核、尾状核FA值的差异无统计学意义（P > 0.05）。结论 早期应用重组人红细胞生成素对早产儿脑白质发育有神经保护作用。
Objective To evaluate the effect of early application of recombinant human erythropoietin (rhEPO) on white matter development in preterm infants using fractional anisotropy (FA) of magnetic resonance diffusion tensor imaging (DTI). Methods A total of 81 preterm infants with gestational age ≤ 32 weeks, birth weight < 1 500 g, and hospitalization within 24 hours after birth were randomly divided into rhEPO group (42 infants) and control group (39 infants). The infants in the rhEPO group were administered rhEPO, while those in the control group were given the same volume of normal saline. The preterm infants of both groups took examinations of head magnetic resonance imaging, diffusion-weighted imaging, and DTI at the corrected gestational age of 35-37 weeks. FA was calculated for the regions of interest in both groups. Results There was no significant difference in the incidence of intracranial hemorrhage, periventricular leukomalacia, focal cerebral white matter damage (CWMD), and extensive CWMD between rhEPO and control groups (P > 0.05). Compared with the control group, the rhEPO group showed higher FA values at the posterior limb of the internal capsule, the splenium of the corpus callosum, frontal white matter, and occipital white matter (P < 0.05). There was no significant difference in FA values at the parietal white matter, thalamus, lenticular nucleus, and caudate nucleus between the two groups (P > 0.05). Conclusions Early application of rhEPO has a neuroprotective effect on white matter development in preterm infants.
重组人促红细胞生成素 / 脑白质发育 / 磁共振弥散张量成像 / 部分各项异性参数 / 早产儿
Recombinant human erythropoietin / White matter development / Diffusion tensor imaging / Fractional anisotropy / Preterm infant
[1] Lawn JE, Blencowe H, Oza S, et al. Every newborn:progress, priorties, and potential beyond survival[J]. Lancet, 2014, 384(9938):189-205.
[2] Zhao X, Chen Y, Qiu G, et al. Reducing preterm births in China[J]. Lancet, 2012, 380(9848):1144-1145.
[3] Woodward LJ, Anderson PJ, Austin NC, et al. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants[J]. N Engl J Med, 2006, 355(7):685-694.
[4] Juul S. Recombinant erythropoietin as a neuroprotective treatment:in vitro and in vivo models[J]. Clin Perinatol, 2004, 31(1):129-142.
[5] van der Kooij MA, Groenendaal F, Kavelaars A, et al. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia[J]. Brain Res Rev, 2008, 59(1):22-33.
[6] Song J, Sun H, Xu F, et al. Recombinant human erythropoietin improves neurological outcomes in very preterm infants[J]. Ann Neurol, 2016, 80(1):24-34.
[7] Pandit AS, Ball G, Edwards AD, et al. Diffusion magnetic resonance imaging in preterm brain injury[J]. Neuroradiology, 2013, 55(Suppl 2):65-95.
[8] 李冰肖, 柳国胜, 凌雪英, 等. MRI和DTI评价早产儿脑白质髓鞘发育[J]. 中国当代儿科杂志, 2016, 18(6):476-481.
[9] Jobe AH, Bancalari E. Bronchopulmonary dysplasia[J]. Am J Respir Crit Care Med, 2001, 163(7):1723-1729.
[10] 中华医学会儿科学分会新生儿学组. 新生儿败血症治疗方案[J]. 中华儿科杂志, 2003, 41(2):897-899.
[11] 邵肖梅, 叶鸿瑁, 邱小汕.实用新生儿科学[M].第4版.北京:人民卫生出版社, 2011:110, 401-408, 477-483, 706-713, 715-719, 887-892.
[12] 陈丹, 毛健, 李娟, 等. 晚期早产儿CWMD临床特点及磁共振影像学发现[J]. 中国当代儿科杂志, 2010, 12(5):321-326.
[13] Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants[J]. Cochrane Database Syst Rev, 2006, 5(3):CD004863.
[14] Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy[J]. Pediatrics, 2009, 124(2):e218-226.
[15] Juul SE, Pet GC. Erythropoietin and neonatal neuroprotection[J]. Clin Perinatol, 2015, 42(3):469-481.
[16] Juul S. Neuroprotective role of erythropoietin in neonates[J]. J Matern Fetal Neonatal Med, 2012, 25(4):105-107.
[17] 刘骁, 毛健, 李娟, 等. 早产儿微小型脑白质损伤的MRI-DTI评价[J]. 中国当代儿科杂志, 2015, 17(6):554-559.
[18] Arfanakis K, Haughton VM, Carew JD, et al. Diffusion tensor MR imagine in diffuse axonal injury[J]. AJNR Am J Neuroradiol, 2002, 23(5):794-802.
[19] 王淑霞. 3.0 T MRI、扩散加权成像和扩散张量成像在早产儿脑病的应用研究[D]. 武汉:华中科技大学, 2012.
[20] Ling X, Tang W, Liu G, et al. Assessment of brain maturation in the preterm infants using diffusion tensor imaging (DTI) and enhanced T2 star weighted angiography (ESWAN)[J]. Eur J Radiol, 2013, 82(9):e476-483.
[21] Robinson S, Li Q, Dechant A, et al. Neonatal loss of gammaaminobutyric acid pathway expression after human perinatal brain injury[J]. J Neurosurg, 2006, 104(6):396-408.
[22] Back SA, Luo NL, Mallinson RA, et al. Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes[J]. Ann Neurol, 2005, 58(1):108-120.
[23] Liu W, Shen Y, Plane JM, et al. Neuroprotective potential of erythro-poietin and its derivative carbamylated erythropoietin in periventricular leukomalacia[J]. Experiment Neurol, 2011, 230(2):227-239.
[24] O'Gorman RL, Bucher HU, Held U, et al. Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants[J]. Brain, 2015, 138(Pt2):388-397.
[25] Natalucci G, Latal B, Koller B, et al. Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 Years:A randomized clinical trial[J]. JAMA, 2016, 315(19):2079-2085.
